Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Establishment Labs Holdings Inc

Healthcare US ESTA

72.41USD
2.00(2.84%)

Last update at 2026-06-03T20:00:00Z

Day Range

69.6972.93
LowHigh

52 Week Range

28.8983.31
LowHigh

Fundamentals

  • Previous Close 70.41
  • Market Cap1882.39M
  • Volume276863
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-29.44500M
  • Revenue TTM211.08M
  • Revenue Per Share TTM7.13
  • Gross Profit TTM 146.31M
  • Diluted EPS TTM-1.72

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -58.02200M -84.62800M -78.58300M -72.82400M -39.71200M
Minority interest - - - - -
Net income -51.06400M -84.59600M -78.50200M -75.20900M -41.13900M
Selling general administrative 165.07M 139.81M 143.54M 125.98M 92.23M
Selling and marketing expenses - - - - -
Gross profit 146.31M 109.53M 106.98M 106.59M 85.40M
Reconciled depreciation 10.47M 7.58M 4.63M 4.34M 4.12M
Ebit - -63.79900M -63.19000M -39.65800M -25.14000M
Ebitda -32.76600M -56.22200M -58.30700M -42.74800M -31.38700M
Depreciation and amortization - 7.58M 4.88M -3.09000M -6.24700M
Non operating income net other - - - -21.40600M -5.51000M
Operating income -39.00800M -49.98700M -65.02600M -39.65800M -25.14000M
Other operating expenses 250.08M 216.01M 230.18M 201.36M 151.82M
Interest expense 25.26M 20.83M 15.39M 11.76M 9.06M
Tax provision -6.95800M -0.03200M 3.24M 2.38M 1.43M
Interest income 0.42M 1.48M 0.54M 0.09M 0.02M
Net interest income -24.83300M -19.35200M -12.71400M -11.67300M -9.03900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -6.95800M -0.03200M -0.08100M 2.38M 1.43M
Total revenue 211.08M 166.03M 165.15M 161.70M 126.68M
Total operating expenses 185.32M 159.51M 172.00M 146.25M 110.54M
Cost of revenue 64.77M 56.50M 58.17M 55.10M 41.28M
Total other income expense net -19.01400M -34.64100M -13.55700M -33.16600M -14.57200M
Discontinued operations - - - - -
Net income from continuing ops -51.06400M -84.59600M -71.52200M -75.20900M -41.13900M
Net income applicable to common shares - - - -75.20900M -41.13900M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 357.17M 346.83M 268.64M 211.06M 139.53M
Intangible assets 9.94M 11.68M 7.99M 4.61M 4.37M
Earning assets - - - - -
Other current assets 11.26M 8.92M 8.01M 11.54M 2.64M
Total liab 333.62M 293.74M 250.25M 219.25M 88.79M
Total stockholder equity 23.55M 53.09M 18.39M -8.18500M 50.74M
Deferred long term liab - - - - -
Other current liab 24.91M 34.23M 12.92M 16.55M 16.24M
Common stock 433.38M 420.36M 315.63M 223.64M 219.74M
Capital stock 433.38M 420.36M 315.63M 223.64M 219.74M
Retained earnings -495.75600M -444.69200M -360.09600M -281.59400M -206.38500M
Other liab - - - 1.63M 3.10M
Good will 1.21M 1.21M 0.47M 0.47M 0.47M
Other assets - - - 1.29M 0.56M
Cash 75.57M 90.35M 40.03M 66.36M 53.41M
Cash and equivalents - - - - -
Total current liabilities 82.14M 68.28M 57.15M 38.96M 31.89M
Current deferred revenue - 1.75M 1.84M 1.69M 0.77M
Net debt 188.90M 134.95M 152.19M 112.31M 0.39M
Short term debt 14.12M 1.51M 0.77M 0.69M 0.40M
Short long term debt 12.41M - - - -
Short long term debt total 264.47M 225.29M 192.22M 178.66M 53.81M
Other stockholder equity 84.77M 74.14M 60.89M 47.06M 33.73M
Property plant equipment - - - 51.09M 20.86M
Total current assets 249.94M 243.04M 174.90M 149.90M 113.27M
Long term investments - - - - -
Net tangible assets - - - -13.25800M 45.90M
Short term investments - - - - -
Net receivables 77.50M 65.00M 46.92M 35.42M 24.44M
Long term debt 247.52M 219.58M 188.74M 175.46M 51.91M
Inventory 85.61M 78.77M 79.94M 36.58M 28.41M
Accounts payable 43.11M 44.76M 41.62M 20.03M 14.47M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.16M 3.29M 1.96M 2.71M 3.66M
Additional paid in capital - - - - -
Common stock total equity - - - 223.64M 219.74M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -281.59400M -206.38500M
Treasury stock - - - - -2.85400M
Accumulated amortization - - - - -
Non currrent assets other 16.12M 7.31M 4.70M 1.29M 0.56M
Deferred long term asset charges - - - - -
Non current assets total 107.23M 103.79M 93.74M 61.16M 26.26M
Capital lease obligations 4.53M 5.72M 3.48M 3.20M 2.30M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -15.61100M -24.54700M -34.79100M -7.16300M
Change to liabilities - - - 7.31M 4.96M
Total cashflows from investing activities -7.02800M - - -34.79100M -7.16300M
Net borrowings 33.48M - - 96.41M -0.17500M
Total cash from financing activities 40.43M 125.89M 86.23M 100.25M 4.05M
Change to operating activities - - - -2.68500M 2.94M
Net income -51.06400M -84.59600M -78.50200M -75.20900M -41.13900M
Change in cash -14.77500M 50.31M -26.32000M 12.94M -31.10800M
Begin period cash flow 90.35M 40.03M 66.36M 53.41M 84.52M
End period cash flow 75.57M 90.35M 40.03M 66.36M 53.41M
Total cash from operating activities -50.89000M -58.51600M -88.51300M -52.16600M -27.53200M
Issuance of capital stock 0.00000M 99.48M 84.54M 84.54M 0.00000M
Depreciation -9.56300M 7.58M 4.88M 4.34M 4.12M
Other cashflows from investing activities -2.66300M -9.44700M -1.32800M -0.52500M -0.43400M
Dividends paid - - - 3.87M 4.23M
Change to inventory -7.06000M -0.47100M -42.23000M -10.90000M -7.64400M
Change to account receivables -11.46900M -26.27800M -11.55700M -12.33300M -6.69500M
Sale purchase of stock - - -0.48400M -0.00400M -0.35600M
Other cashflows from financing activities -0.63700M 1.94M 3.86M 3.87M 4.23M
Change to netincome - - - 22.05M 13.85M
Capital expenditures 6.05M 8.53M 24.55M 34.27M 6.73M
Change receivables - - - -12.33300M -6.69500M
Cash flows other operating - - - 8.79M 11.87M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - 13.30M -30.64300M
Change in working capital -13.17100M -15.49900M -34.12900M -21.54200M -6.44000M
Stock based compensation -11.41500M 14.40M 14.36M 13.36M 10.41M
Other non cash items 27.36M 20.81M 8.58M 26.80M 5.51M
Free cash flow -56.93900M -64.63000M -113.06000M -86.43200M -34.26100M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ESTA
Establishment Labs Holdings Inc		 2.00 2.84% 72.41 - - 8.92 83.52 10.21 -26.2892
ABT
Abbott Laboratories		 0.02 0.02% 86.99 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 1.70 0.58% 295.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 4.20 5.69% 77.95 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.01 0.02% 47.69 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Establishment Labs Holdings Inc

11401 century oaks terrace, Austin, TX, United States, 78758

Key Executives

Name Title Year Born
Mr. Juan Jose Chacon Quiros Founder, CEO & Exec. Director 1972
Mr. Rajbir Singh Denhoy Chief Financial Officer 1970
Mr. Paul D. Rodio Chief Operating Officer 1966
Mr. Roberto de Mezerville Chief Technology Officer 1981
Mr. S. Ross Mansbach Gen. Counsel & Chief Compliance Officer NA
Mr. Jeffrey Clark Bettinger Global Head of People NA
Mr. Salvador Santos Dada Chief Operating Officer (Medical Leave of Absence) 1983
Dr. Heather Brennan Head of U.S. Commercial Operations NA
Ms. Neeta Toprani Corp. Sec. NA
Mr. Juan Jose Chacon Quiros Founder, CEO & Executive Director 1972

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.